Marco Zanfardino
About Marco Zanfardino
Marco Zanfardino is the Lead of Apheresis/Cryo Logistics/PDP CAR-T Supply Chains Operations at Bristol Myers Squibb and an operator in bio services at Eli Lilly and Company.
Company
Marco Zanfardino is currently working at Bristol Myers Squibb in Summit, New Jersey, United States. He holds the position of Lead in Apheresis/Cryo Logistics/PDP CAR-T Supply Chains Operations. Marco also has experience working in a similar capacity at Eli Lilly and Company as an Operator Bio Services.
Title
Marco Zanfardino serves as the Lead for Apheresis/Cryo Logistics/PDP CAR-T Supply Chains Operations at Bristol Myers Squibb. His role involves overseeing the final drug product shipment, collaborating with various departments for quality control, and assisting in FDA Pre-License inspections.
Education and Expertise
Marco Zanfardino studied Business Administration and Management, obtaining a Bachelor of Science (BS) from Fairleigh Dickinson University between 2011 and 2013. He also attended the University of Connecticut from 2008 to 2010 and St. Benedict's Prep School from 2004 to 2008. He possesses extensive experience in cryopreservation logistics and is exceptionally proficient in Oracle Inventory Systems.
Background
Marco Zanfardino has amassed significant experience in the pharmaceutical industry. He was a CAR T Supply Chain Operator at Bristol Myers Squibb from 2020 to 2021 and held a contractual role as Manufacturing Operator II Bio Services at Eli Lilly and Company in 2019. He has a solid foundation in managing cryopreservation logistics, training new hires, and collaborative daily operations with Quality Assurance and quality control teams.
Achievements
Marco Zanfardino has played a critical role in multiple key operational areas at Bristol Myers Squibb. His responsibilities include supervising the receiving dock, handling affluent materials, ensuring temperature control, and managing inventory demand based on manufacturing schedules. Marco also contributes to resolving quality issues and is integral to FDA Pre-License inspections. Additionally, he efficiently leads a team focused on the final drug product shipment, ensuring adherence to Standards of Operations and Safety.